95 related articles for article (PubMed ID: 28778441)
1. Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease.
Caggiu E; Paulus K; Galleri G; Arru G; Manetti R; Sechi GP; Sechi LA
J Neuroimmunol; 2017 Sep; 310():26-31. PubMed ID: 28778441
[TBL] [Abstract][Full Text] [Related]
2. The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease.
White AJ; Wijeyekoon RS; Scott KM; Gunawardana NP; Hayat S; Solim IH; McMahon HT; Barker RA; Williams-Gray CH
Front Neurol; 2018; 9():946. PubMed ID: 30524354
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein triggers T-cell response. Is Parkinson's disease an autoimmune disorder?
Bandres-Ciga S; Cookson MR
Mov Disord; 2017 Sep; 32(9):1327. PubMed ID: 28782845
[No Abstract] [Full Text] [Related]
4. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
[TBL] [Abstract][Full Text] [Related]
5. Erratum: T cells from patients with Parkinson's disease recognize α-synuclein peptides.
Sulzer D; Alcalay RN; Garretti F; Cote L; Kanter E; Agin-Liebes J; Liong C; McMurtrey C; Hildebrand WH; Mao X; Dawson VL; Dawson TM; Oseroff C; Pham J; Sidney J; Dillon MB; Carpenter C; Weiskopf D; Phillips E; Mallal S; Peters B; Frazier A; Arlehamn CSL; Sette A
Nature; 2017 Sep; 549(7671):292. PubMed ID: 28905919
[TBL] [Abstract][Full Text] [Related]
6. Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
Doucet M; El-Turabi A; Zabel F; Hunn BHM; Bengoa-Vergniory N; Cioroch M; Ramm M; Smith AM; Gomes AC; Cabral de Miranda G; Wade-Martins R; Bachmann MF
PLoS One; 2017; 12(8):e0181844. PubMed ID: 28797124
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons.
Qing X; Walter J; Jarazo J; Arias-Fuenzalida J; Hillje AL; Schwamborn JC
Stem Cell Res; 2017 Oct; 24():44-50. PubMed ID: 28826027
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein oligomers: a new hope.
Bengoa-Vergniory N; Roberts RF; Wade-Martins R; Alegre-Abarrategui J
Acta Neuropathol; 2017 Dec; 134(6):819-838. PubMed ID: 28803412
[TBL] [Abstract][Full Text] [Related]
9. Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates.
Jiang P; Gan M; Yen SH; McLean PJ; Dickson DW
Sci Rep; 2017 Aug; 7(1):7690. PubMed ID: 28794446
[TBL] [Abstract][Full Text] [Related]
10. Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.
Kempuraj D; Thangavel R; Selvakumar GP; Zaheer S; Ahmed ME; Raikwar SP; Zahoor H; Saeed D; Natteru PA; Iyer S; Zaheer A
Front Cell Neurosci; 2017; 11():216. PubMed ID: 28790893
[TBL] [Abstract][Full Text] [Related]
11. Updates on immunity and inflammation in Parkinson disease pathology.
Joshi N; Singh S
J Neurosci Res; 2018 Mar; 96(3):379-390. PubMed ID: 29072332
[TBL] [Abstract][Full Text] [Related]
12. Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide.
Mohammadi S; Nikkhah M; Hosseinkhani S
Protein Pept Lett; 2017; 24(8):757-764. PubMed ID: 28820063
[TBL] [Abstract][Full Text] [Related]
13. Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.
Pavlos R; McKinnon EJ; Ostrov DA; Peters B; Buus S; Koelle D; Chopra A; Schutte R; Rive C; Redwood A; Restrepo S; Bracey A; Kaever T; Myers P; Speers E; Malaker SA; Shabanowitz J; Jing Y; Gaudieri S; Hunt DF; Carrington M; Haas DW; Mallal S; Phillips EJ
Sci Rep; 2017 Aug; 7(1):8653. PubMed ID: 28819312
[TBL] [Abstract][Full Text] [Related]
14. Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling.
Ong ZY; Liu JJ; Pang ZP; Grill HJ
Neuropsychopharmacology; 2017 Nov; 42(12):2387-2397. PubMed ID: 28811669
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.
Sheng XJ; Tu HJ; Chien WL; Kang KH; Lu DH; Liou HH; Lee MJ; Fu WM
PLoS One; 2017; 12(8):e0183076. PubMed ID: 28806787
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia impairs agonist-induced integrin α
Kiouptsi K; Gambaryan S; Walter E; Walter U; Jurk K; Reinhardt C
Sci Rep; 2017 Aug; 7(1):7621. PubMed ID: 28790378
[TBL] [Abstract][Full Text] [Related]
17. A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air Provocation.
Singh U; Bernstein JA; Lorentz H; Sadoway T; Nelson V; Patel P; Salapatek AM
Int Arch Allergy Immunol; 2017; 173(3):153-164. PubMed ID: 28787742
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-210 and miR-155 expression levels as novel biomarkers for rheumatoid arthritis diagnosis.
Abdul-Maksoud RS; Sediq AM; Kattaia A; Elsayed W; Ezzeldin N; Abdel Galil SM; Ibrahem RA
Br J Biomed Sci; 2017 Oct; 74(4):209-213. PubMed ID: 28782994
[TBL] [Abstract][Full Text] [Related]
19. On the hypoxic tumor targeting ability of two chitosan micelles loaded with oil-soluble CdSe quantum dots.
Zhang S; Zhao L; Qiu N; Liu Y; Xu B; Zhu H
Pharm Dev Technol; 2018 Jan; 23(1):87-95. PubMed ID: 28782455
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
